An Open-label Phase 2a Study to Evaluate the Safety and Tolerability of Perampanel (E2007) in Subjects With Cervical Dystonia (SAFE-Per CD)
Phase of Trial: Phase I/II
Latest Information Update: 01 Nov 2017
At a glance
- Drugs Perampanel (Primary)
- Indications Torticollis
- Focus Adverse reactions
- Acronyms SAFE-Per CD
- 24 Oct 2017 Planned End Date changed from 1 Sep 2016 to 1 Dec 2018.
- 24 Oct 2017 Planned primary completion date changed from 1 Jan 2016 to 1 Sep 2018.
- 24 Oct 2017 Status changed from not yet recruiting to recruiting.